These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27127813)

  • 61. Trailblazing cancer-physics project accused of losing ambition.
    Popkin G
    Nature; 2015 Aug; 524(7563):14-5. PubMed ID: 26245557
    [No Abstract]   [Full Text] [Related]  

  • 62. Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health.
    Hum Gene Ther; 2001 Nov; 12(17):2129-51. PubMed ID: 11747602
    [No Abstract]   [Full Text] [Related]  

  • 63. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
    Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
    PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Canstatin induces apoptosis in gastric cancer xenograft growth in mice through the mitochondrial apoptotic pathway.
    Xing YN; Deng P; Xu HM
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Developing a xenograft human tumor model in immunocompetent mice.
    Basel MT; Narayanan S; Ganta C; Shreshta TB; Marquez A; Pyle M; Hill J; Bossmann SH; Troyer DL
    Cancer Lett; 2018 Jan; 412():256-263. PubMed ID: 29054784
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Moving ahead with personalized mouse models.
    Bender E
    Cancer Discov; 2013 Nov; 3(11):1214. PubMed ID: 24203942
    [No Abstract]   [Full Text] [Related]  

  • 68. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
    Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
    Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Establishment of a novel experimental model of human angiosarcoma and a VEGF-targeting therapeutic experiment.
    Hoshina D; Abe R; Yoshioka N; Saito N; Hata H; Fujita Y; Aoyagi S; Shimizu H
    J Dermatol Sci; 2013 May; 70(2):116-22. PubMed ID: 23522954
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Imaging as a biomarker for therapy response: cancer as a prototype for the creation of research resources.
    McLennan G; Clarke L; Hohl RJ
    Clin Pharmacol Ther; 2008 Oct; 84(4):433-6. PubMed ID: 18802422
    [No Abstract]   [Full Text] [Related]  

  • 71. Nab-paclitaxel is an active drug in preclinical model of pediatric solid tumors.
    Zhang L; Marrano P; Kumar S; Leadley M; Elias E; Thorner P; Baruchel S
    Clin Cancer Res; 2013 Nov; 19(21):5972-83. PubMed ID: 23989978
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.
    Meetze K; Vincent S; Tyler S; Mazsa EK; Delpero AR; Bottega S; McIntosh D; Nicoletti R; Winston WM; Weiler S; Feng B; Gyuris J; Weng Z
    Clin Cancer Res; 2015 Mar; 21(5):1106-14. PubMed ID: 25542901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The NCI Biospecimen Research Network.
    Moore HM
    Biotech Histochem; 2012 Jan; 87(1):18-23. PubMed ID: 21745162
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection.
    Li Y; Zhang R; Han Y; Lu T; Ding J; Zhang K; Lin G; Xie J; Li J
    Diagn Pathol; 2016 Sep; 11(1):85. PubMed ID: 27613595
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
    Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
    Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
    [TBL] [Abstract][Full Text] [Related]  

  • 76. XePhIR: the zebrafish xenograft phenotype interactive repository.
    Groenewoud A; Forn-Cuní G; Engel FB; Snaar-Jagalska BE
    Database (Oxford); 2022 Apr; 2022():. PubMed ID: 35482537
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [In silico exploration of databases is no longer a fighting sport].
    Robert J
    Bull Cancer; 2021 Jan; 108(1):14-17. PubMed ID: 33422338
    [No Abstract]   [Full Text] [Related]  

  • 78. Looking at xenografts in zebrafish.
    Vogt N
    Nat Methods; 2019 Jul; 16(7):578. PubMed ID: 31249414
    [No Abstract]   [Full Text] [Related]  

  • 79. Reproducible pharmacogenomic profiling of cancer cell line panels.
    Haverty PM; Lin E; Tan J; Yu Y; Lam B; Lianoglou S; Neve RM; Martin S; Settleman J; Yauch RL; Bourgon R
    Nature; 2016 May; 533(7603):333-7. PubMed ID: 27193678
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
    Quail DF; Bowman RL; Akkari L; Quick ML; Schuhmacher AJ; Huse JT; Holland EC; Sutton JC; Joyce JA
    Science; 2016 May; 352(6288):aad3018. PubMed ID: 27199435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.